Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
RELL1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
EPHA5 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
CNR1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
EMC7 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
FZD1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Profile neighbors
ZNF365 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
PSMG4 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
LOC101927211 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors
YY1AP1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
AKAP8 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
TRIB3 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
APOBEC4 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
CCDC174 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
NAGLU - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
AGER - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
ZNF419 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on